SCHEMBL276519

SCHEMBL276519

[c]1ccc2ccscc1-2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL276590 0.88
SCHEMBL6103317 0.70 PDGFRB (0.42)
SCHEMBL196071 0.70 CYP2A6 (0.58)
SCHEMBL1439053 0.70 CYP2A6 (0.52)
SCHEMBL17350220 0.69 CYP2A6 (0.40)
SCHEMBL3576853 0.67 CYP2A6 (0.43)
SCHEMBL980077 0.64 DAO (0.32)
SCHEMBL26516 0.63 ALDH1A1 (0.42)
SCHEMBL6653596 0.63 CYP2A6 (0.43)
SCHEMBL3778177 0.63 CYP2A6 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 833 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149452-A1 COMBINATION TREATMENT OF LIVER DISORDERS Terns Pharmaceuticals, Inc. (US) 2023-03-22 EP claimed
EP-4149453-A1 COMBINATION TREATMENT OF LIVER DISORDERS Terns Pharmaceuticals, Inc. (US) 2023-03-22 EP claimed
CN-115811973-A Combination therapy for liver disorders 拓臻制药公司 2023-03-17 CN claimed
CN-115811972-A Combination therapy for liver disorders 拓臻制药公司 2023-03-17 CN claimed
WO-2021231646-A1 COMBINATION TREATMENT OF LIVER DISORDERS TERNS PHARMACEUTICALS, INC. (US) 2021-11-18 WO claimed
WO-2021231644-A1 COMBINATION TREATMENT OF LIVER DISORDERS TERNS PHARMACEUTICALS, INC. (US) 2021-11-18 WO claimed
US-20210244744-A1 TREATING LIVER DISORDERS Terns, Inc. 2021-08-12 US claimed
EP-3844156-A1 TREATING LIVER DISORDERS Terns Pharmaceuticals, Inc. (US) 2021-07-07 EP claimed
CN-112771026-A Treating liver disorders 拓臻制药公司 2021-05-07 CN claimed
CN-109096253-B 2- (4-pyridyl) substituted benzimidazole compound and application of emulsion in water thereof in preventing and treating wheat powdery mildew 山东农业大学 2020-03-31 CN claimed
US-5955481-A Pyridine type thiazolidines NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1999-09-21 US claimed
WO-1998023617-A1 HETERO-BIARYL-PYRIDOQUINAZOLINONE DERIVATIVES AS ANTI-CANCER AGENTS AMERICAN CYANAMID COMPANY (US) 1998-06-04 WO claimed
EP-0828724-A1 DIARYL-5-OXYGENATED-2-(5H)-FURANONES AS COX-2 INHIBITORS MERCK FROSST CANADA INC. (CA) 1998-03-18 EP claimed
US-5691374-A ENZYME INHIBITORS OF CYCLOOXYGENASE AS ANTIINFLAMMATORY AGENTS MERCK FROSST CANADA INC. (CA) 1997-11-25 US claimed
EP-0799218-A1 DIARYL-2-(5H)-FURANONES AS COX-2 INHIBITORS MERCK FROSST CANADA INC. (CA) 1997-10-08 EP claimed
CN-1144526-A Thiazolidines and oxazolidines substituted by pyridine ring and their use a hypoglycemic agents NISSAN CHEMICAL IND LTD (JP) 1997-03-05 CN claimed
EP-0751944-A1 THIAZOLIDINES AND OXAZOLIDINES SUBSTITUTED BY A PYRIDINE RING AND THEIR USE AS HYPOGLYCEMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1997-01-08 EP claimed
WO-1996036623-A1 DIARYL-5-OXYGENATED-2-(5H)-FURANONES AS COX-2 INHIBITORS MERCK FROSST CANADA INC. (CA) 1996-11-21 WO claimed
WO-1996019469-A1 DIARYL-2-(5H)-FURANONES AS COX-2 INHIBITORS MERCK FROSST CANADA INC. (CA) 1996-06-27 WO claimed
WO-1995026347-A1 THIAZOLIDINES AND OXAZOLIDINES SUBSTITUTED BY A PYRIDINE RING AND THEIR USE AS HYPOGLYCEMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1995-10-05 WO claimed